Filgrastim for treatment of neutropenia in a neonate.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  American Journal of Health-System Pharmacy

• Publication date

  1999-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/AJHP/56.10.995PMID 10365725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A two-year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life.

  1996cited by this paper
• Effect of granulocyte colony-stimulating factor on preeclampsia-associated neonatal neutropenia.

  1995cited by this paper
• The in vitro effects of stem cell factor, interleukin 3 and granulocyte‐macrophage colony stimulating factor on haemopoietic progenitor cells from premature infants

  1994cited by this paper
• Production of granulocyte colony-stimulating factor in vitro by monocytes from preterm and term neonates.

  1993cited by this paper
• Effects of hemopoietic growth factors on stem cells in vitro.

  1989cited by this paper
• Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells

  1985cited by this paper
• Sepsis neonatorum.

  1981cited by this paper
• Neutrophil and band counts in the diagnosis of neonatal infections.

  1974cited by this paper

• No citing papers are available for this paper.